Distinct Laboratory and Clinical Features of Metabolic and Alcohol-Related Liver Disease (MetALD): A Systematic Review and Meta-Analysis - PubMed
5 days ago
- #Liver Disease
- #MetALD
- #Meta-Analysis
- MetALD is a newly recognized subtype of steatotic liver disease (SLD) with synergistic effects of metabolic dysfunction and alcohol consumption.
- Compared to MASLD, MetALD shows higher AST, ALT, GGT, triglycerides, HDL-C, and blood pressure, but lower BMI and HbA1c.
- Compared to ALD, MetALD has lower liver enzymes but similar metabolic parameters.
- The study analyzed 33 studies involving 7,504,674 individuals.
- Findings suggest MetALD as a distinct entity requiring further research.